Blue Cross NC policies

Search Blue Cross NC's public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.

Checking prior authorization for S0265? Open Blue Cross NC’s official lists and confirm the member’s product there.

29 policies name S0265, those listing the fewest codes first. A policy that names a code may also list it as excluded.

Blue Cross NC policies
PolicyDetailsCodesSource
Genetic Testing for Fanconi Anemia AHS – M2077M2077 · Commercial5Original policy ↗
Genetic Testing for Li-Fraumeni Syndrome AHS – M2081M2081 · Commercial5Original policy ↗
Familial Adenomatous Polyposis and MUTYH-Associated Polyposis AHSM2024AHSM2024 · Commercial6Original policy ↗
Genetic Testing for PTEN Hamartoma Tumor Syndrome AHS – M2087M2087 · Commercial6Original policy ↗
Genetic Testing for Familial Alzheimer’s Disease AHS – M2038M2038 · Commercial7Original policy ↗
Genetic Testing for Familial Alzheimer’s Disease AHS – M2038M2038 · Commercial7Original policy ↗
Genetic Testing for Familial Alzheimer’s DiseaseAHS – M2038 · Commercial8Original policy ↗
Genetic Testing for FMR1 Mutations AHS – M2028M2028 · Commercial9Original policy ↗
Genetic Testing for Polyposis Syndromes AHS-M2024AHS-M2024 · Commercial9Original policy ↗
Genetic Testing for Diagnosis of Inherited Peripheral Neuropathies AHS – M2072M2072 · Commercial10Original policy ↗
Chromosomal Microarray and Low-pass Whole Genome Sequencing AHS - M2033M2033 · Commercial11Original policy ↗
Genetic Cancer Susceptibility Panels Using Next Generation Sequencing AHS - M2066M2066 · Commercial11Original policy ↗
Genetic Testing for Fanconi Anemia AHS – M2077M2077 · Commercial11Original policy ↗
Genetic Testing for Hereditary Hearing Loss AHS – G2148G2148 · Commercial11Original policy ↗
Genetic Testing for Alpha- and Beta- Thalassemia AHS - M2131M2131 · Commercial12Original policy ↗
Testing of Homocysteine Metabolism Related Conditions AHS - M2141M2141 · Commercial13Original policy ↗
Testing of Homocysteine Metabolism Related Conditions AHS - M2141 NotificationM2141 · Commercial13Original policy ↗
Genetic Testing for Cardiac Ion Channelopathies AHS – 2025Commercial14Original policy ↗
Genetic Testing for Inherited Cardiomyopathies and Channelopathies AHS – M2025M2025 · Commercial17Original policy ↗
Genetic Testing for Neurofibromatosis and Related Disorders AHS – M2134M2134 · Commercial19Original policy ↗
Genetic Testing of Mitochondrial Disorders AHS – M2085M2085 · Commercial22Original policy ↗
General Genetic Testing, Somatic Disorders AHS-M2146AHS-M2146 · Commercial54Original policy ↗
Genetic Testing for Neurodegenerative Disorders AHS – M2167M2167 · Commercial60Original policy ↗
Genetic Testing for Cystic Fibrosis AHS – M2017M2017 · Commercial64Original policy ↗
General Genetic Testing, Germline Disorders AHS – M2145M2145 · Commercial77Original policy ↗
Pre-Implantation Genetic Testing AHS - M2039M2039 · Commercial83Original policy ↗
General Genetic Testing, Germline Disorders AHS - M2145M2145 · Commercial109Original policy ↗
TelehealthCommercial176Original policy ↗
Health Care Reform Preventive Services Coding GuideCommercial307Original policy ↗

Back to Blue Cross NC · Blue Cross NC prior authorization CPT list

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.